Hodgson Russ Assists UMES In Securing U.S. Patent For Epilepsy Drug


The Hodgson Russ Intellectual Property & Technology Team has successfully assisted the University of Maryland Eastern Shore (UMES) in obtaining a U.S. Patent for a chemical formula treatment for epilepsy. The medical research project that led to this discovery was spearheaded by Dr. Patrice Jackson-Ayotunde, Ph.D., an Associate Professor of Pharmaceutical Sciences at UMES. 65 million people suffer from epilepsy and one in 26 Americans will be diagnosed at some point in their lifetime. Dr. Jackson-Ayotunde focused her research regarding the design and synthesis of novel anticonvulsant analogs as potential agents for treatment of therapy-resistant partial epilepsy. Read the official UMES press release on the patent here: https://www.umes.edu/PR/News-Articles/2018/New-epilepsy-treatment-idea-emerges-at-UMES/

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.